Riverview Trust Co bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,220 shares of the pharmacy operator’s stock, valued at approximately $70,000.
A number of other large investors have also recently added to or reduced their stakes in the business. Highlander Capital Management LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $26,000. Pineridge Advisors LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $26,000. Venturi Wealth Management LLC boosted its stake in Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the period. Rocky Mountain Advisers LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $30,000. Finally, Quest Partners LLC acquired a new position in Walgreens Boots Alliance in the 4th quarter worth approximately $30,000. 58.59% of the stock is currently owned by institutional investors.
Insider Activity at Walgreens Boots Alliance
In other news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CFO Manmohan Mahajan purchased 6,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on WBA
Walgreens Boots Alliance Price Performance
Shares of Walgreens Boots Alliance stock opened at $15.70 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The firm’s 50-day simple moving average is $16.76 and its 200-day simple moving average is $20.36. Walgreens Boots Alliance, Inc. has a twelve month low of $14.62 and a twelve month high of $31.88. The firm has a market cap of $13.54 billion, a P/E ratio of -2.24, a price-to-earnings-growth ratio of 0.99 and a beta of 0.78.
Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last issued its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. During the same period in the previous year, the business earned $1.16 EPS. The firm’s revenue was up 6.3% on a year-over-year basis. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current fiscal year.
Walgreens Boots Alliance Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 6.37%. The ex-dividend date of this dividend was Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Recommended Stories
- Five stocks we like better than Walgreens Boots Alliance
- What is the S&P/TSX Index?
- Chipotle Mexican Grill Stock Split: Where Does it Go From Here?
- 3 Warren Buffett Stocks to Buy Now
- Arm Holdings and Micron: Top 2 AI Stocks to Buy and Hold
- The How and Why of Investing in Gold Stocks
- Best Buy Stock May Be Best Bought Before the Holiday Season
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.